Skip to content
Peptigraph home

Tirzepatide for Energy: What the Evidence Shows

What human and animal studies show about Tirzepatide for energy, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGLP-1 / GIP dual agonistUpdated
Strongest evidence
None graded
no study with an outcome for energy (PubMed search, 2 Oct 2026)
Human studies
None found
with an outcome for energy, in our evidence file (PubMed search, 2 Oct 2026)
Animal studies
None found
with an outcome for energy, in our evidence file (PubMed search, 2 Oct 2026)

Evidence for energy

None of the study abstracts we summarised for Tirzepatide reported an outcome for energy (PubMed search, 2 Oct 2026). Claims that it helps with energy are unproven.

How strong is it?

Strongest evidence:No graded study for energy (PubMed search, 2 Oct 2026)

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Fatigue in the label's trial tables

MedlinePlus says fatigue is a feeling of weariness, tiredness or lack of energy, and is usually a symptom of something else.[16]

The Zepbound label's weight-reduction table lists fatigue (including asthenia, lethargy and malaise) at 3% on placebo and 5%, 6% and 7% on tirzepatide 5, 10 and 15 mg.[17]

Fatigue is on the Zepbound highlights list of most common adverse reactions.[17]

Energy intake is not energy levels

A secondary analysis found tirzepatide, like semaglutide, lowered appetite scores and energy intake at a test lunch; that is about calories eaten, not how energetic a person feels.[18]

The authors conclude that differences in lunch energy intake were not enough to explain the different weight outcomes.[18]

Possible causes of tiredness on treatment

Low blood sugar is one cause the Mounjaro leaflet lists, including weakness and drowsiness.[19]

Other peptides people research for energy

All peptides for energy, compared

Common questions

Does Tirzepatide help with energy?

None of the studies we summarised for Tirzepatide (PubMed search, 2 Oct 2026) measured an outcome for energy. Treat claims that it helps with energy as unproven.

Is Tirzepatide approved for energy?

Tirzepatide is FDA approved (Mounjaro, Zepbound). Which conditions that approval covers is set by the label; use for anything else is off-label.

What is the best peptide for energy?

There is no single answer. Our energy overview compares each candidate by evidence grade and legal status rather than by popularity.

Does tirzepatide cause fatigue?

Yes, in the Zepbound pooled trials fatigue was reported by 7% on the 15 mg dose against 3% on placebo.[17]

Will tirzepatide boost my energy?

No study we cached measured energy levels as an outcome, so there is nothing to cite for it.[18]

More on Tirzepatide

Sources

  1. 1PubMed search: tirzepatide[ti] AND (SURMOUNT[tiab] OR SURPASS[tiab]) AND randomized controlled trial[pt] (93 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  2. 2PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-4 OR SURPASS-5 OR "versus semaglutide" OR "SURPASS-CVOT" OR dulaglutide) (143 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  3. 3PubMed search: tirzepatide[ti] AND (steatohepatitis OR NASH OR "heart failure" OR HFpEF OR "preserved ejection" OR cardiovascular) (410 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  4. 4PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-1 OR SURPASS-5 OR "SURPASS J-mono") AND randomized controlled trial[pt] (24 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: tirzepatide[ti] AND (steatohepatitis OR "heart failure" OR "SUMMIT" OR "SYNERGY-NASH" OR "phase 2") AND randomized controlled trial[pt] (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: tirzepatide[tiab] AND (meta-analysis[pt] OR systematic review[pt]) AND (weight OR glycemic OR HbA1c OR obesity) (178 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: tirzepatide[tiab] AND (pharmacokinetic*[tiab] OR half-life[tiab]) AND humans[mh] (49 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  8. 8PubMed search: tirzepatide[ti] AND (insulin degludec OR "SURPASS-3") AND "type 2 diabetes"[ti] AND randomized controlled trial[pt] (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9PubMed search: tirzepatide[ti] AND (cardiovascular outcomes OR "SURPASS-CVOT" OR "major adverse") (228 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  10. 10PubMed search: tirzepatide[tiab] AND (depression OR anxiety OR ADHD OR osteoporosis OR "bone mineral" OR menopause OR "rheumatoid" OR arthritis OR testosterone) (121 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  11. 11PubMed search: tirzepatide[tiab] AND ("body composition"[tiab] OR "lean mass"[tiab] OR "visceral fat"[tiab] OR "fat mass"[tiab]) AND humans[mh] (91 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  12. 12PubMed search: tirzepatide[tiab] AND (blood pressure[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  13. 13PubMed search: tirzepatide[tiab] AND (SURPASS-CVOT OR "cardiovascular events" ) AND "dulaglutide"[tiab] AND randomized controlled trial[pt] (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  14. 14PubMed search: tirzepatide[tiab] AND (depression[tiab] OR anxiety[tiab] OR "mental health"[tiab] OR ADHD[tiab] OR "binge eating"[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  15. 15PubMed search: tirzepatide[tiab] AND (menopaus*[tiab] OR PCOS[tiab] OR "polycystic"[tiab] OR testosterone[tiab] OR hypogonadism[tiab]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  16. 16Official web pageOfficial web page · web page
  17. 17ZEPBOUND prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  18. 18Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.Diabetes care · 2023PMID 36857477Accessed 2 Oct 2026
  19. 19MOUNJARO prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.